Assisted Reproductive Technology Market to Hit USD 38.48 Billion by 2030 owing to the growing need to overcome infertility.

The SNS Insider report indicates that the Assisted Reproductive Technology Market was valued at USD 24.7 Billion in 2022, and is expected to reach market size of USD 38.48 Billion by 2030, with a compound annual growth rate (CAGR) of 5.70% expected over the forecast period from 2023 to 2030.

Based on SNS Insider's research, in order to inform the public about fertility complications and treatment options, public awareness campaigns have been stepped up by government and nongovernmental organisations.

Market Report Scope -

The market for in vitro fertilisation, i.e. a common ART procedure, is the focus of this study. It highlights innovations around the pre-implantation genetic testing (PGT) of embryos and the use of artificial intelligence (AI) and predictive tools in IVF for improving clinical decision-making and outcomes. The study provides a short introduction to each of these technologies and analyses their benefits and applications, as well as identifies some major players that are offering solutions deriving from them.

Get sample PDF Assisted Reproductive Technology Market Report@ https://www.snsinsider.com/sample-request/3447

The major key players Assisted Reproductive Technology Market
-Cosmos Biomedical,
-Microm, CooperSurgical,
-Fujifilm Irvine Scientific,
-Cryolab, Vitrolife,
-European Sperm Bank,
-Bloom IVF Centre,
-Merck KGaA,
-Ferring B.V.
- and other

Market Opportunities-

Technological advancements
Depending on the patient's needs, various techniques such as in vitro fertilization (IVF), artificial insemination, zygote intra-fallopian transfer (ZIFT), and gamete intra-fallopian transfer (GIFT) are used. Due to the high success rate of embryo transfer and increased birth rates, vitro fertilization is deemed a gold standard for assisted reproductive technologies. To prepare the body for ART treatment, drugs such as orals and injectable hormones are used both before and during the treatment. The pharmaceutical market is projected to increase considerably in the coming years, thanks to a comprehensive pipeline. In addition, in vivo ART devices have been developed by INVOcell and Anecova that are expected to contribute to market growth during the forecast period.

Assisted Reproductive Technology Market Segmentation Analysis -

By Type
-In-Vitro Fertilization
-Artificial Insemination

By End-Use Outlook
-Fertility Clinics & Other Facilities
-Hospitals & Care

The industry has been divided into in vitro fertilisation and artificial insemination on the basis of type. In 2022, the IVF segment had a maximum share of 91,90% worldwide revenues. By IVF, the industry is further segmented into fresh donor, frozen donor, fresh non-donor, and frozen non-donor. The frozen non-donor segment held a significant revenue share in 2021. The growth can be attributed to the benefits associated with frozen nondonor, as opposed to other forms of in vitro fertilization. The frozen non-donor procedure is used when the woman is releasing healthy eggs and undergoing ART due to male infertility or fallopian tube malformation.

The worldwide industry has also been divided on the basis of end use, namely fertility clinics and ancillary healthcare establishments as well as others. In 2022, the segment Fertility Clinics & Other End use Facilities accounted for more than 79.93% of total revenues, and held a dominant position in the world market. The segment is expected to expand further at the fastest rate over the forecast period, maintaining its prominent position in this sector. The high share and rapid growth can be attributed to a rise in the number of infertility cases and the need for a specialized place to perform ART.

Need Customized Report as per Your Business Requirement Ask Here @ https://www.snsinsider.com/enquiry/3447

Key Regional Development -

In 2022, Europe became the largest revenue generator, with over 36.98% of its revenues coming from it. The high share is attributed to a rise in the infertility rate, increased awareness about fertility treatments, technological advancements, and supportive government initiatives. For instance, according to the European Society of Human Reproduction and Embryology, approximately 25 million of the European Union Population are suffering from infertility, which is the highest globally. During the forecast period, North America is expected to grow strongly. The rise is due to the positive results observed in patients who have been treated.

Key Takeaway from Assisted Reproductive Technology Market Study-

A strength, weakness, opportunities, and threats (SWOT) analysis of the PGT and AI technology segments has also been offered, as well as a future outlook of each technology.

The study provides an industry assessment, including a look at the patent landscape of the sector and the factors that are driving and restraining growth. The report also identifies and assesses the main growth opportunities for technology developers within this sector.

Recent Development Related to Assisted Reproductive Technology Market -

In December 2023, TMRW Life Sciences, a fertility technology company, announced its expansion in the United Kingdom Fertility Market. The first clinic outside the US to adopt TMRW's automated storage platform for frozen eggs and embryos was the Liverpool Fertility Centre in England.

In 2022, Inception Fertility expanded its ecosystem by launching HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides fertility providers and patients with a one-of-a-kind experience. This includes technologies for assisted reproduction.

Buy Assisted Reproductive Technology Market Report @ https://www.snsinsider.com/checkout/3447

TABLE OF CONTENTS

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
5. Value Chain Analysis
6. Porter's 5 forces model
7. PEST Analysis
8. Assisted Reproductive Technology Market Segmentation, by Type
8.1 In-Vitro Fertilization
8.2 Artificial Insemination
9. Assisted Reproductive Technology Market Segmentation, by End Use Outlook
9.1 Fertility Clinics & Other Facilities
9.2 Hospitals & Care
10. Regional Analysis
11 Company Profile
12.Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.4 Industry News
12.5 Company News
12.6 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
continued

Access Complete Report Details with Toc and Graphs@ https://www.snsinsider.com/reports/assisted-reproductive-technology-market-3447

Contact Us:
Akash Anand - Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

This release was published on openPR.